Published in Reprod Biol Endocrinol on November 03, 2011
Follicular Fluid, Bioavailable Vitamin D and Embryo Quality Markers | NCT03073720
Impact of GnRH agonist triggering and intensive luteal steroid support on live-birth rates and ovarian hyperstimulation syndrome: a retrospective cohort study. J Ovarian Res (2013) 0.80
Spontaneous ovarian hyperstimulation syndrome following a thawed embryo transfer cycle. Clin Exp Reprod Med (2014) 0.75
A case of severe ovarian hyperstimulation syndrome. Indian J Clin Biochem (2013) 0.75
Predictive factors for recovery time in patients suffering from severe OHSS. Reprod Biol Endocrinol (2014) 0.75
Gonadotropin-releasing hormone agonist triggering is effective, even at a low dose, for final oocyte maturation in ART cycles: Case series. J Turk Ger Gynecol Assoc (2015) 0.75
Acute Abdomen in the 17th Week of Twin Pregnancy due to Ovarian Torsion - A Late Complication of IVF. Geburtshilfe Frauenheilkd (2016) 0.75
Can we eliminate severe ovarian hyperstimulation syndrome? Hum Reprod (2004) 3.03
GnRH agonist for triggering of final oocyte maturation: time for a change of practice? Hum Reprod Update (2011) 2.15
Anti-Müllerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology. Hum Reprod (2006) 1.87
Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles. Fertil Steril (2006) 1.81
Preventing ovarian hyperstimulation syndrome: guidance for the clinician. Fertil Steril (2010) 1.72
Cryopreservation of human embryos by vitrification or slow freezing: a systematic review and meta-analysis. Fertil Steril (2007) 1.71
Live birth rates after transfer of equal number of blastocysts or cleavage-stage embryos in IVF. A systematic review and meta-analysis. Hum Reprod (2007) 1.66
Serum anti-Müllerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles. Hum Reprod (2007) 1.54
Current progress in oocyte and embryo cryopreservation by slow freezing and vitrification. Reproduction (2010) 1.46
GnRH-antagonists in ovarian stimulation for IVF in patients with poor response to gonadotrophins, polycystic ovary syndrome, and risk of ovarian hyperstimulation: a meta-analysis. Reprod Biomed Online (2006) 1.37
Ovarian volume and antral follicle count for the prediction of low and hyper responders with in vitro fertilization. Reprod Biol Endocrinol (2007) 1.23
Distinction between early and late ovarian hyperstimulation syndrome. Fertil Steril (2000) 1.21
1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study. Fertil Steril (2009) 1.18
Gonadotrophin-releasing hormone antagonists for assisted conception: a Cochrane review. Reprod Biomed Online (2007) 1.17
Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study. Fertil Steril (2008) 1.10
Early and late ovarian hyperstimulation syndrome: early pregnancy outcome and profile. Hum Reprod (2004) 1.05
Symposium: Update on prediction and management of OHSS. Prevention of OHSS. Reprod Biomed Online (2009) 1.02
Reducing the dose of human chorionic gonadotropin in high responders does not affect the outcomes of in vitro fertilization. Fertil Steril (2004) 1.00
Cycles triggered with GnRH agonist: exploring low-dose HCG for luteal support. Reprod Biomed Online (2009) 0.90
Severe OHSS: yes, there is a strategy to prevent it! Hum Reprod (2000) 0.86
Prediction of ovarian hyperstimulation syndrome: why predict if we can prevent! Hum Reprod (2003) 0.84
Identification of the high-risk patient for ovarian hyperstimulation syndrome. Semin Reprod Med (2010) 0.84
Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomized controlled trial. Hum Reprod (2004) 3.56
Consistent high clinical pregnancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: a retrospective multicentre study. Hum Reprod (2013) 2.23
European Association of Urology guidelines on Male Infertility: the 2012 update. Eur Urol (2012) 2.20
Letrozole and gonadotropins versus luteal estradiol and gonadotropin-releasing hormone antagonist protocol in women with a prior low response to ovarian stimulation. Fertil Steril (2011) 2.12
Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles. Fertil Steril (2006) 1.81
Homozygous mutation in SPATA16 is associated with male infertility in human globozoospermia. Am J Hum Genet (2007) 1.71
Live birth rates after transfer of equal number of blastocysts or cleavage-stage embryos in IVF. A systematic review and meta-analysis. Hum Reprod (2007) 1.66
What about gr/gr deletions and male infertility? Systematic review and meta-analysis. Hum Reprod Update (2010) 1.66
Sperm chromatin structure assay parameters measured after density gradient centrifugation are not predictive for the outcome of ART. Hum Reprod (2007) 1.60
Orthotopic grafting of cryopreserved prepubertal testicular tissue: in search of a simple yet effective cryopreservation protocol. Fertil Steril (2012) 1.52
Genetic causes of spermatogenic failure. Asian J Androl (2011) 1.51
Modified natural cycle for IVF does not offer a realistic chance of parenthood in poor responders with high day 3 FSH levels, as a last resort prior to oocyte donation. Hum Reprod (2004) 1.47
Thyroid function after controlled ovarian hyperstimulation in women with and without the hyperstimulation syndrome. Fertil Steril (2011) 1.42
Testicular cell transplantation into the human testes. Fertil Steril (2013) 1.42
Exposure to high levels of luteinizing hormone and estradiol in the early follicular phase of gonadotropin-releasing hormone antagonist cycles is associated with a reduced chance of pregnancy. Fertil Steril (2003) 1.32
Mild ovarian stimulation for IVF: 10 years later. Hum Reprod (2010) 1.26
Effect of oral contraceptive pill pretreatment on ongoing pregnancy rates in patients stimulated with GnRH antagonists and recombinant FSH for IVF. A randomized controlled trial. Hum Reprod (2005) 1.23
Septate uterus with cervical duplication: a full-term delivery after resection of a vaginal septum. Fertil Steril (2004) 1.22
GnRHa trigger and modified luteal support with one bolus of hCG should be used with caution in extreme responder patients. Hum Reprod (2013) 1.18
Prolongation of the follicular phase in in vitro fertilization results in a lower ongoing pregnancy rate in cycles stimulated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists. Fertil Steril (2004) 1.14
Male infertility and the involvement of the X chromosome. Hum Reprod Update (2009) 1.13
Assisted reproduction and thyroid autoimmunity: an unfortunate combination? J Clin Endocrinol Metab (2003) 1.11
Spermatogonial survival after grafting human testicular tissue to immunodeficient mice. Hum Reprod (2005) 1.10
Optimal usage of the GnRH antagonists: a review of the literature. Reprod Biol Endocrinol (2013) 1.09
The effect of luteal phase vaginal estradiol supplementation on the success of in vitro fertilization treatment: a prospective randomized study. Fertil Steril (2007) 1.09
Improving the patient's experience of IVF/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatment. Hum Reprod (2009) 1.08
GnRH agonist triggering: recent developments. Reprod Biomed Online (2012) 1.08
An excess of chromosome 1 breakpoints in male infertility. Eur J Hum Genet (2004) 1.06
Early and late ovarian hyperstimulation syndrome: early pregnancy outcome and profile. Hum Reprod (2004) 1.05
Human embryonic stem cell lines derived from single blastomeres of two 4-cell stage embryos. Hum Reprod (2009) 1.05
Progesterone rise on the day of human chorionic gonadotropin administration impairs pregnancy outcome in day 3 single-embryo transfer, while has no effect on day 5 single blastocyst transfer. Fertil Steril (2007) 1.04
Triggering of final oocyte maturation with gonadotropin-releasing hormone agonist or human chorionic gonadotropin. Live birth after frozen-thawed embryo replacement cycles. Fertil Steril (2007) 1.04
Chromosomal segregation in spermatozoa of 14 Robertsonian translocation carriers. Mol Hum Reprod (2006) 1.03
Autologous spermatogonial stem cell transplantation in man: current obstacles for a future clinical application. Hum Reprod Update (2008) 0.99
LH-receptor gene expression in human granulosa and cumulus cells from antral and preovulatory follicles. J Clin Endocrinol Metab (2012) 0.99
Live delivery rates in subfertile women with Asherman's syndrome after hysteroscopic adhesiolysis using the resectoscope or the Versapoint system. Reprod Biomed Online (2004) 0.98
Thyroid dysfunction and autoimmunity in infertile women. Thyroid (2002) 0.98
The four blastomeres of a 4-cell stage human embryo are able to develop individually into blastocysts with inner cell mass and trophectoderm. Hum Reprod (2008) 0.98
Getting pregnant after tubal sterilization: surgical reversal or IVF? Hum Reprod (2007) 0.98
Oral contraceptive pretreatment significantly reduces ongoing pregnancy likelihood in gonadotropin-releasing hormone antagonist cycles: an updated meta-analysis. Fertil Steril (2010) 0.97
Biological versus chronological ovarian age: implications for assisted reproductive technology. Reprod Biol Endocrinol (2009) 0.97
Corifollitropin alfa followed by rFSH in a GnRH antagonist protocol for poor ovarian responder patients: an observational pilot study. Fertil Steril (2012) 0.97
The impact of male overweight on semen quality and outcome of assisted reproduction. Asian J Androl (2014) 0.97
Preovulatory progesterone concentration associates significantly to follicle number and LH concentration but not to pregnancy rate. Reprod Biomed Online (2011) 0.97
Prolongation of follicular phase by delaying hCG administration results in a higher incidence of endometrial advancement on the day of oocyte retrieval in GnRH antagonist cycles. Hum Reprod (2005) 0.96
Intracytoplasmic sperm injection with testicular spermatozoa is less successful in men with nonobstructive azoospermia than in men with obstructive azoospermia. Fertil Steril (2003) 0.96
Abnormal sperm in mice with targeted deletion of the act (activator of cAMP-responsive element modulator in testis) gene. Proc Natl Acad Sci U S A (2004) 0.95
Empty follicle syndrome after GnRHa triggering versus hCG triggering in COS. J Assist Reprod Genet (2012) 0.94
Luteal phase estradiol versus luteal phase estradiol and antagonist protocol for controlled ovarian stimulation before in vitro fertilization in poor responders. Fertil Steril (2010) 0.94
Dose of recombinant FSH and oestradiol concentration on day of HCG affect embryo development kinetics. Reprod Biomed Online (2012) 0.94
Spermatogonial survival in long-term human prepubertal xenografts. Fertil Steril (2008) 0.94
Effects and clinical significance of GnRH antagonist administration for IUI timing in FSH superovulated cycles: a meta-analysis. Fertil Steril (2007) 0.94
Do we need to search for gr/gr deletions in infertile men in a clinical setting? Hum Reprod (2008) 0.93
Impact of ovarian hyperstimulation on thyroid function in women with and without thyroid autoimmunity. J Clin Endocrinol Metab (2004) 0.93
Hormonal, functional and genetic biomarkers in controlled ovarian stimulation: tools for matching patients and protocols. Reprod Biol Endocrinol (2012) 0.92
The type of GnRH analogue used during controlled ovarian stimulation influences early embryo developmental kinetics: a time-lapse study. Eur J Obstet Gynecol Reprod Biol (2013) 0.92
The choice and outcome of the fertility treatment of 38 couples in whom the male partner has a Yq microdeletion. Hum Reprod (2005) 0.92
Health and the financial crisis in Greece. Lancet (2012) 0.91
Sonographic changes after laparoscopic cystectomy compared with three-stage management in patients with ovarian endometriomas: a prospective randomized study. Hum Reprod (2009) 0.90
Dual trigger of oocyte maturation with gonadotropin-releasing hormone agonist and low-dose human chorionic gonadotropin to optimize live birth rates in high responders. Fertil Steril (2012) 0.89
Cumulative delivery rates after ICSI in women aged >37 years. Hum Reprod (2002) 0.89
GnRH agonist ovulation trigger and hCG-based, progesterone-free luteal support: a proof of concept study. Hum Reprod (2011) 0.89
Psychological aspects of male fertility treatment. J Adv Nurs (2012) 0.89
Predictive value of embryo grading for embryos with known outcomes. Fertil Steril (2009) 0.89
Possible role of USP26 in patients with severely impaired spermatogenesis. Eur J Hum Genet (2005) 0.89
Corticotropin-releasing hormone (CRH) and immunotolerance of the fetus. Biochem Pharmacol (2003) 0.88
Monozygotic twinning is not increased after single blastocyst transfer compared with single cleavage-stage embryo transfer. Fertil Steril (2009) 0.88
A prospective study, using sibling oocytes, examining the effect of 30 seconds versus 90 minutes gamete co-incubation in IVF. Hum Reprod (2005) 0.88
Initiation of gonadotropin-releasing hormone antagonist on day 1 as compared to day 6 of stimulation: effect on hormonal levels and follicular development in in vitro fertilization cycles. J Clin Endocrinol Metab (2003) 0.88
Duration of gonadotropin-releasing hormone antagonist administration does not affect the outcome of subsequent frozen-thawed cycles. Fertil Steril (2004) 0.88
In vitro maturation (IVM) of oocytes recovered from ovariectomy specimens in the laboratory: a promising "ex vivo" method of oocyte cryopreservation resulting in the first report of an ongoing pregnancy in Europe. J Assist Reprod Genet (2015) 0.87
Recombinant human follicle-stimulating hormone (r-hFSH) plus recombinant luteinizing hormone versus r-hFSH alone for ovarian stimulation during assisted reproductive technology: systematic review and meta-analysis. Reprod Biol Endocrinol (2014) 0.87
Pregnancy loss after frozen-embryo transfer--a comparison of three protocols. Fertil Steril (2012) 0.86
Agonist trigger: what is the best approach? Agonist trigger with aggressive luteal support. Fertil Steril (2012) 0.86
Administration of gonadotropin-releasing hormone antagonist from day 1 of stimulation in in vitro fertilization. Fertil Steril (2004) 0.86
Human chorionic gonadotropin administration vs. luteinizing monitoring for intrauterine insemination timing, after administration of clomiphene citrate: a meta-analysis. Fertil Steril (2006) 0.86
Ovarian hyperstimulation syndrome after gonadotropin-releasing hormone agonist triggering and "freeze-all": in-depth analysis of genetic predisposition. J Assist Reprod Genet (2015) 0.86
Sertoli cell-conditioned medium induces germ cell differentiation in human embryonic stem cells. J Assist Reprod Genet (2011) 0.86
Is there a role for the nuclear export factor 2 gene in male infertility? Fertil Steril (2008) 0.86
Outcome for donors and recipients in two egg-sharing policies. Fertil Steril (2003) 0.86
Three decades after Gjönnaess's laparoscopic ovarian drilling for treatment of PCOS; what do we know? An evidence-based approach. Arch Gynecol Obstet (2013) 0.86
Cryosurvival and spermatogenesis after allografting prepubertal mouse tissue: comparison of two cryopreservation protocols. Fertil Steril (2007) 0.85
LH (as HCG) and FSH surges for final oocyte maturation: sometimes it takes two to tango? Reprod Biomed Online (2010) 0.85
Experimental emotional disclosure in women undergoing infertility treatment: Are drop outs better off? Soc Sci Med (2009) 0.85
Thyroid function after assisted reproductive technology in women free of thyroid disease. Fertil Steril (2005) 0.85
Regeneration of spermatogenesis by grafting testicular tissue or injecting testicular cells into the testes of sterile mice: a comparative study. Fertil Steril (2008) 0.85